Credit Rating Information and Services Limited (CRISL) has assigned the rating of The ACME Laboratories as “AA-” in the long-term, said an official disclosure on Monday”.
The rating agency also rated “ST-3” in the short-term along with a stable outlook in consideration of its audited financials up to 30 June 2017, un-audited financials up to 30 September 2017 and other relevant quantitative as well as qualitative information up to the date of rating declaration, the disclosure said.
The ACME Laboratories, which listed on the Dhaka bourse in 2016 under book-building method, has approved 35 per cent cash dividend for the year ended on June 30, 2017.
The company’s annual general meeting (AGM) held today (Monday) at 10:30am at PSC Convention Hall at Mirpur in Dhaka.
In 2016, the country’s oldest pharma company also disbursed 35 per cent cash dividend.
Each share of the company closed at Tk 113.20 on Sunday at the Dhaka Stock Exchange (DSE).
The company’s paid-up capital is Tk 2.11 billion and authorised capital is Tk 5.0 billion, while the total number of securities is 211.60 million.
Sponsor-directors own 40.01 per cent stake in the company while the institutional investors own 27.17 per cent, foreign 3.57 per cent and the general public 29.25 per cent as on October 31, 2017, the DSE data shows.
